Polen Capital Management — REGN Trade History
Quarter-by-quarter changes in the REGENERON PHARMACEUTICALS position · CUSIP 75886F107
Sold outFirst seen: 2016 Q3
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-04 | — | — | — | — | — | — |
| 2026 Q1 | 2026-05-14 | — | — | — | — | — | — |
| 2025 Q4 | 2026-02-12 | — | — | — | — | — | — |
| 2025 Q3 | 2025-11-12 | — | — | — | — | — | — |
| 2025 Q2 | 2025-08-13 | — | — | — | — | — | — |
| 2025 Q1 | 2025-05-12 | — | — | — | — | — | — |
| 2024 Q3 | 2025-02-10 | — | — | — | — | — | — |
| 2024 Q4 | 2025-02-10 | — | — | — | — | — | — |
| 2024 Q2 | 2024-08-12 | — | — | — | — | — | — |
| 2023 Q4 | 2024-05-10 | — | — | — | — | — | — |
| 2024 Q1 | 2024-05-10 | — | — | — | — | — | — |
| 2023 Q3 | 2023-11-13 | — | — | — | — | — | — |
| 2023 Q2 | 2023-08-11 | — | — | — | — | — | — |
| 2023 Q1 | 2023-05-11 | — | — | — | — | — | — |
| 2022 Q4 | 2023-02-13 | — | — | — | — | — | — |
| 2022 Q3 | 2022-11-04 | — | — | — | — | — | — |
| 2022 Q2 | 2022-08-10 | Sold out | — | -1,383 | -100.0% | — | — |
| 2022 Q1 | 2022-05-12 | Reduce | 1,383 | -555 | -28.6% | $966.0K | 0.00% |
| 2021 Q4 | 2022-02-11 | Reduce | 1,938 | -217 | -10.1% | $1.2M | 0.00% |
| 2021 Q3 | 2021-11-10 | New | 2,155 | 2,155 | — | $1.3M | 0.00% |
| 2021 Q2 | 2021-08-12 | — | — | — | — | — | — |
| 2021 Q1 | 2021-05-12 | Sold out | — | -2,002,804 | -100.0% | — | — |
| 2020 Q4 | 2021-02-11 | Add | 2,002,804 | 65,147 | +3.4% | $967.6M | 2.25% |
| 2020 Q3 | 2020-11-12 | Add | 1,937,657 | 93,123 | +5.0% | $1.08B | 2.90% |
| 2020 Q2 | 2020-08-13 | Add | 1,844,534 | 123,532 | +7.2% | $1.15B | 3.48% |
| 2020 Q1 | 2020-05-11 | Add | 1,721,002 | 44,708 | +2.7% | $840.3M | 3.65% |
| 2019 Q4 | 2020-02-06 | Add | 1,676,294 | 34,084 | +2.1% | $629.4M | 2.48% |
| 2019 Q3 | 2019-11-12 | Add | 1,642,210 | 57,097 | +3.6% | $455.5M | 2.10% |
| 2019 Q2 | 2019-08-12 | Reduce | 1,585,113 | -17,448 | -1.1% | $496.1M | 2.40% |
| 2019 Q1 | 2019-05-13 | Add | 1,602,561 | 117,306 | +7.9% | $658.0M | 3.44% |
| 2018 Q4 | 2019-02-12 | New | 1,485,255 | 1,485,255 | — | $554.7M | 3.62% |
| 2018 Q3 | 2018-11-13 | — | — | — | — | — | — |
| 2018 Q2 | 2018-08-09 | — | — | — | — | — | — |
| 2018 Q1 | 2018-05-11 | — | — | — | — | — | — |
| 2017 Q4 | 2018-02-09 | — | — | — | — | — | — |
| 2017 Q3 | 2017-11-13 | — | — | — | — | — | — |
| 2017 Q2 | 2017-08-10 | — | — | — | — | — | — |
| 2017 Q1 | 2017-05-11 | — | — | — | — | — | — |
| 2016 Q4 | 2017-02-13 | — | — | — | — | — | — |
| 2016 Q3 | 2016-11-14 | — | — | — | — | — | — |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.